Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Eclipta alba extract may help hair grow similarly to Minoxidil.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.